MXL NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

MaxLinear Inc · Technology · Semiconductors

Latest close 74.98 USD
12.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 40.4% above the Trend Line and sits at 53.8% of its 52-week range. The latest completed week returned 12.2%, after a -17.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is mixed with 38/100 conviction, while the latest news-sentiment score is 61/100. Near-term considerations: volume confirmation is below normal; earnings are due in 70d.

Setup score 44 out of 100
Latest Close 74.98 USD 7 Aug 2026
1W Return 12.2% latest completed week
4W Return -17.9% short-term follow-through
12W Return -18.8% quarterly tape
Trend Breadth 90.4% 47 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • The trend backdrop is active with a 19-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 4 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 40.4% above the Trend Line and sits at 53.8% of its 52-week range. The latest completed week returned 12.2%, after a -17.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7912-week average 0.88

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.79Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -17.9% over four weeks, -18.8% over 12 weeks, and 395.6% over one year. The current trend has remained active for 19 consecutive weeks.

Performance by holding period

1W12.2%
4W-17.9%
12W-18.8%
26W300.5%
52W395.6%
Active trend streak19 weeks
Active weeks in one year47
Trend breadth90.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.62Latest activity-pressure read.
Pressure change-216.5%Four-week change in activity pressure.
Leadership84.87Latest relative-leadership reading.
RS change-43.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2026 Field coverage 85% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength17/100Blend of value, momentum, and quality. Underlying universe rank 84; rank 1 is best.
Value8/100Relative valuation strength. Underlying universe rank 93; rank 1 is best.
Quality16/100Profitability and accounting quality. Underlying universe rank 85; rank 1 is best.
Momentum100/100Medium-term price momentum. Underlying universe rank 1; rank 1 is best.
Growth86/100Revenue and earnings growth. Underlying universe rank 15; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
12.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
57.4%
Gross profit retained from each unit of revenue.
Operating margin
-13.4%
Operating profit retained from revenue.
Free-cash-flow margin
5.2%
Free cash flow generated from revenue.
Return on invested capital
-10.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
50.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.2%
Net share repurchases relative to market value.
Shareholder yield
0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

MXL shows mixed options pressure with a 38/100 conviction score, put-call volume ratio of 1.28, expected move of 13.4%, and Sharemaestro trend signal active.

Conviction38/100
Expected move13.4%
Put/call volume1.28
Pressure-6
Speculation40
Volatility96
Trend agreement66
Open options detail
Insider activity8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment61/100

Weighted news tone is positive across 31 relevant articles.

13 positive · 15 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings70dNext report is scheduled for 22 Oct 2026; event risk rises as the date approaches.
Options expected move13.4%Nearest-chain priced movement where available.
52-week drawdown-41.6%Distance below the 52-week high.
13-week volatility9.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+129.6%Week of 24 Apr.
Worst week-21.3%Week of 17 Jul.
Latest week+12.2%Week of 7 Aug.

Shape of recent returns

Strong gains13
Modest gains1
Flat weeks0
Modest losses4
Sharp losses8
Recent vol9.1%13-week weekly-return volatility.
Base vol20.2%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew13.3% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202674.98 USD12.2%53.42 USD24.08 USD-0.6284.8712.2MOn
31 Jul 202666.82 USD-6.7%51.55 USD23.74 USD-0.3377.8621.9MOn
24 Jul 202671.59 USD-0.3%49.94 USD23.47 USD-0.0196.4130.9MOn
17 Jul 202671.84 USD-21.3%48.14 USD23.17 USD0.2799.3915.8MOn
10 Jul 202691.30 USD-2.0%46.34 USD22.93 USD0.53149.7613.9MOn
3 Jul 202693.12 USD-3.6%43.87 USD22.55 USD0.67169.5121.1MOn
26 Jun 202696.60 USD8.8%41.40 USD22.15 USD0.78194.1220.6MOn
19 Jun 202688.76 USD5.1%38.70 USD21.73 USD0.93170.4911.7MOn
12 Jun 202684.46 USD4.4%36.19 USD21.35 USD1.14175.6018.4MOn
5 Jun 202680.92 USD-12.9%33.84 USD21.00 USD1.34182.2726.7MOn
29 May 202692.93 USD-6.3%31.63 USD20.67 USD1.51223.5724.2MOn
22 May 202699.16 USD7.4%29.04 USD20.26 USD1.62274.4820.1MOn
15 May 202692.34 USD-7.5%26.26 USD19.81 USD1.69275.5427.1MOn
8 May 202699.83 USD29.3%23.74 USD19.41 USD1.66330.0427.2MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context